These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 12209694)

  • 1. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
    Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
    Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
    Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
    Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases.
    Somali M; Mpatakoias V; Avramides A; Sakellari I; Kaloyannidis P; Smias C; Anagnostopoulos A; Kourtis A; Rousso D; Panidis D; Vagenakis A
    Gynecol Endocrinol; 2005 Jul; 21(1):18-26. PubMed ID: 16048797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
    Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
    J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late effects in children after bone marrow transplantation: a review.
    Locatelli F; Giorgiani G; Pession A; Bozzola M
    Haematologica; 1993; 78(5):319-28. PubMed ID: 8314162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health status and late complications following allogeneic bone marrow transplantation. A review].
    Tichelli A; Gratwohl A; Uhr M; Dazzi H; Hoffmann T; Stebler Gysi C; Walther E; Roth J; Hünig R; Nissen C
    Schweiz Med Wochenschr; 1991 Oct; 121(41):1473-81. PubMed ID: 1947943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine disorders during the first year after autologous stem-cell transplant.
    Tauchmanovà L; Selleri C; De Rosa G; Esposito M; Di Somma C; Orio F; Palomba S; Lombardi G; Rotoli B; Colao A
    Am J Med; 2005 Jun; 118(6):664-70. PubMed ID: 15922699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.
    Miralbell R; Sancho G; Bieri S; Carrió I; Helg C; Brunet S; Martin PY; Sureda A; Gomez De Segura G; Chapuis B; Estorch M; Ozsahin M; Keller A
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):809-16. PubMed ID: 14967438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
    Pérez-Simón JA; Díez-Campelo M; Martino R; Brunet S; Urbano A; Caballero MD; de León A; Valcárcel D; Carreras E; del Cañizo MC; López-Fidalgo J; Sierra J; San Miguel JF
    Br J Haematol; 2005 Aug; 130(3):394-403. PubMed ID: 16042689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.
    Katsanis E; Shapiro RS; Robison LL; Haake RJ; Kim T; Pescovitz OH; Ramsay NK
    Bone Marrow Transplant; 1990 May; 5(5):335-40. PubMed ID: 2350628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients.
    Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM
    Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subnormal androgen levels in young female bone marrow transplant recipients with ovarian dysfunction, chronic GVHD and receiving glucocorticoid therapy.
    Hovi L; Saarinen-Pihkala UM; Taskinen M; Wikström AM; Dunkel L
    Bone Marrow Transplant; 2004 Mar; 33(5):503-8. PubMed ID: 14716348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine dysfunction after total body irradiation and bone marrow transplantation.
    Feyer P; Titlbach O; Hoffmann FA; Kubel M; Helbig W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):547-52. PubMed ID: 2480306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL).
    Steffens M; Beauloye V; Brichard B; Robert A; Alexopoulou O; Vermylen Ch; Maiter D
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):819-27. PubMed ID: 18429947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.